laboratori corpor america hold
diagnost drive modest upsid quarter guidanc narrow
confer call held thursday octob et updat model
estim confer call dial-in passcod
revenu billion beat billion target street billion
diagnost lcd billion beat billion target
covanc cdd billion miss billion target
adjust ep beat target consensu estim
return equiti ttm
manag narrow outlook revenu expect grow
inclus headwind divestitur headwind currenc
compar previou rang inclus headwind
divestitur headwind currenc adjust ep expect
previou rang free cash flow expect
million billion unchang
labcorp second-largest independ clinic laboratori unit state nation network
primari laboratori patient servic center compani perform routin laboratori test
specimen day built lead platform esoter test
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
lcd outlook improv revenu expect includ fx headwind basi point
neg impact divestitur compar previou rang pama headwind
lcd revenu growth third quarter compar full-year guidanc basi point
cdd outlook narrow revenu expect grow includ fx headwind compar
previou rang
updat model follow today confer call current model call revenu billion
adjust ep
stock share sit time adjust ep target three-year averag time view remain
compel long-term entri point continu believ compani effort build scale diversifi
cro busi leverag labcorp broad patient access lead higher revenu growth case
covanc independ diagnost side intrigu potenti rapidli grow walgreen
collabor continu believ earli inning secular shift market share lower-cost larger lab
given medicar reimburs pressur increas effort part privat payer reduc lab spend strateg
way compani deliv solid execut year-to-d despit face steepest year pama cut share
loss expect investor continu get comfort ep rang long-term growth outlook
maintain outperform rate
william blair affili market maker secur laboratori corpor america hold
william blair affili expect receiv intend seek compens invest bank servic laboratori corpor
america hold affili within next three month
offic employe william blair affili research analyst may financi interest secur
laboratori corpor america hold
report avail electron form regist user via doc http //williamblairlibrari bluematrix com
pleas contact us consult williamblair com/research-and-insights/equity-research/coverag aspx disclosur
matt larew attest view express research report accur reflect his/her person view
secur compani cover report part his/her compens relat directli indirectli
specif recommend view express him/her report seek updat research appropri
certain period industri report major report publish irregular interv deem appropri research
la bora ori corpora ion rica hold ra ing hist ori
power bluematrix
op outperform market market perform perform nr rate initi coverag drop coverag
current rate distribut octob
addit inform avail upon request
percentag compani rate categori invest bank client defin compani william blair
receiv compens invest bank servic within past month
compens research analyst base varieti factor includ perform stock recommend
contribut firm depart includ asset manag corpor financ institut sale retail brokerag firm
profit competit factor
